Racial/Ethnic Minority Youth With Recent-Onset Type 1 Diabetes Have Poor Prognostic Factors
Author:
Redondo Maria Jose1ORCID, Libman Ingrid2, Cheng Peiyao3, Kollman Craig3, Tosur Mustafa1ORCID, Gal Robin L.3ORCID, Bacha Fida1ORCID, Klingensmith Georgeanna J.4, Clements Mark56, Redondo Maria Jose, Tosur Mustafa, Tamborlane William, Klingensmith Georgeanna, Clements Mark A., Hannon Tamara S., Heptulla Rubina, Less Joane, Shoemaker Ashley, Haymond Morey, Bacha Fida, Johnson Elizabeth, Gomez David, Halter Alix, McDonald Andrene, Fisher Lynda, Wood Jamie, Ichihara Brian, Lipton Megan, Shah Sejal, Shah Avni, Buckingham Bruce, Hsu Liana, Haro Heidi, Manseau Katherine, Silverstein Janet, Schatz Desmond, Haller Michael J., Lyles Teresa, Thomas Jamie, Van Name Michelle, Cengiz Eda, Steffen Amy, Duran Elvira, Finnegan Jennifer, M. Lee Joyce, Bashir Surair, Eason Ashley, W. Beck Roy, C. Beaulieu Lindsey, Cheng Peiyao, L. Gal Robin, Kollman Craig, Mouse TJ, Reese Samantha, J. Ruedy Katrina,
Affiliation:
1. Baylor College of Medicine, Texas Children’s Hospital, Houston, TX 2. Division of Pediatric Endocrinology and Diabetes, Children’s Hospital of Pittsburgh of University of Pittsburgh Medical Center, Pittsburgh, PA 3. Jaeb Center for Health Research, Tampa, FL 4. Barbara Davis Center for Childhood Diabetes, Department of Pediatrics, University of Colorado, Aurora, CO 5. Children’s Mercy Kansas City, Kansas City, MO 6. University of Missouri-Kansas City, Kansas City, MO
Abstract
OBJECTIVE
To compare races/ethnicities for characteristics, at type 1 diabetes diagnosis and during the first 3 years postdiagnosis, known to influence long-term health outcomes.
RESEARCH DESIGN AND METHODS
We analyzed 927 Pediatric Diabetes Consortium (PDC) participants <19 years old (631 non-Hispanic white [NHW], 216 Hispanic, and 80 African American [AA]) diagnosed with type 1 diabetes and followed for a median of 3.0 years (interquartile range 2.2–3.6). Demographic and clinical data were collected from medical records and patient/parent interviews. Partial remission period or “honeymoon” was defined as insulin dose–adjusted hemoglobin A1c (IDAA1c) ≤9.0%. We used logistic, linear, and multinomial regression models, as well as repeated-measures logistic and linear regression models. Models were adjusted for known confounders.
RESULTS
AA subjects, compared with NHW, at diagnosis, were in a higher age- and sex-adjusted BMI percentile (BMI%), had more advanced pubertal development, and had higher frequency of presentation in diabetic ketoacidosis, largely explained by socioeconomic factors. During the first 3 years, AA subjects were more likely to have hypertension and severe hypoglycemia events; had trajectories with higher hemoglobin A1c, BMI%, insulin doses, and IDAA1c; and were less likely to enter the partial remission period. Hispanics, compared with NHWs, had higher BMI% at diagnosis and over the three subsequent years. During the 3 years postdiagnosis, Hispanics had higher prevalence of dyslipidemia and maintained trajectories of higher insulin doses and IDAA1c.
CONCLUSIONS
Youth of minority race/ethnicity have increased markers of poor prognosis of type 1 diabetes at diagnosis and 3 years postdiagnosis, possibly contributing to higher risk of long-term diabetes complications compared with NHWs.
Funder
Novo Nordisk, Inc. Boehringer Ingelheim Takeda
Publisher
American Diabetes Association
Subject
Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|